等待開盤 12-18 09:30:00 美东时间
+0.090
+5.36%
ImmunoPrecise Antibodies (NASDAQ:HYFT) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.01) by 600 percent. This is unchanged from the same period last year. The company
12-15 21:42
MindWalk (NASDAQ:HYFT), a BioNative AI biotherapeutic research and technology company combining in silico and wet lab operations for biologics discovery and development, today announced financial results for the second
12-15 21:39
Companies Reporting Before The Bell • MindWalk Holdings (NASDAQ:HYFT) is likely...
12-15 19:11
Shares of MindWalk Holdings Corp. (NASDAQ:HYFT) rose sharply in pre-market trad...
12-15 17:54
Stock futures up, focus on HYFT, ARGX, NAVN, AXR, CSBR as they report earnings. Top 2 energy stocks to watch for potential plunge this month.
12-15 15:42
ImmunoPrecise Antibodies (NASDAQ:HYFT) will release its quarterly earnings repo...
12-12 22:00
MindWalk Holdings Corp.™ ("MindWalk," "Company," "we" or "us") (NASDAQ:HYFT), bio-native AI company today announces the appointment of industry veteran R. Scott Areglado as Chief Financial Officer (CFO), effective
10-21 20:29
MindWalk Holdings (NASDAQ:HYFT) has authorized a share repurchase program of up to 2.3M common shares. The buyback represents ~5% of the company’s 46.15M shares outstanding. The program will run from ...
10-09 19:41
MindWalk Holdings Corp. ("MindWalk" or the "Company") (NASDAQ: "HYFT"), a bio-native AI company, today announced that to underscore its confidence in MindWalk's future development and growth prospects, its Board of
10-09 19:09